ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,586 Cr | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,586 Cr |
| Mar2025 | ₹7,709 Cr |
| Mar2024 | ₹6,341 Cr |
| Mar2023 | ₹6,064 Cr |
| Mar2022 | ₹7,230 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,586 Cr | 11.38 | |
| Mar2025 | ₹7,709 Cr | 21.57 | |
| Mar2024 | ₹6,341 Cr | 4.58 | |
| Mar2023 | ₹6,064 Cr | -16.13 | |
| Mar2022 | ₹7,230 Cr | - | |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,131.0 Cr | -0.3% | 3.3% | -15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -0.3% |
3.3% |
-15% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses